{"id":"W4417419178","doi":"10.1093/bjd/ljaf485","title":"Open-label treatment extension of ruxolitinib cream in vitiligo: findings from the Topical Ruxolitinib Evaluation in Vitiligo (TRuE-V) long-term extension phase III study","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research; Barrie Urology Group; University of Toronto","funders":"Incyte","keywords":"Ruxolitinib; Vitiligo; Clinical trial; Duration (music); Cohort","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002383652,0.0004128851,0.001176665,0.0001944729,0.0002279107,0.0007478469,0.0004523081,0.0008454827,0.003496319],"category_scores_gemma":[0.001303755,0.0002004088,0.001215497,0.000196529,0.0003655214,0.0007007602,0.0002594225,0.002033266,0.0006372119],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003904589,"about_ca_system_score_gemma":0.0004506198,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004063259,"about_ca_topic_score_gemma":0.001664203,"domain_scores_codex":[0.9993332,0.0003440068,0.00003747745,0.00007214928,0.0000946534,0.0001183771],"domain_scores_gemma":[0.9988942,0.0003668334,0.0002314463,0.0001340669,0.00008865684,0.0002847932],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4679312,0.0455556,0.008581733,0.00246631,0.002821781,0.000404153,0.0004420186,0.002101455,0.08425652,0.0004765486,0.005767831,0.3791948],"study_design_scores_gemma":[0.3094289,0.6013112,0.0627628,0.0002553496,0.001498034,0.0009355542,0.0001987473,0.001843336,0.009392633,0.0004372929,0.01186225,0.00007381623],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9854856,0.008341115,0.0007233833,0.000377278,0.0001331809,0.001005532,0.001230923,0.00007030424,0.002632683],"genre_scores_gemma":[0.9910339,0.002935667,0.001207583,0.0006707803,0.000149714,0.0006409444,0.001395807,0.0000179644,0.001947796],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003496319,"threshold_uncertainty_score":0.01260608,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04065782231475665,"score_gpt":0.3763890620810534,"score_spread":0.3357312397662967,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}